GO
Loading...

Cost/Benefit Challenge of New Cancer Drugs

Monday, 22 Aug 2011 | 11:22 AM ET

Insight on how to price a drug after 14 years of development and more than half a billion of R&D, with Clay Siegall, Seattle Genetics president/CEO.